Ignite Creation Date:
2025-12-24 @ 12:08 PM
Ignite Modification Date:
2026-04-13 @ 2:08 PM
Study NCT ID:
NCT01038661
Status:
COMPLETED
Last Update Posted:
2014-02-28
First Post:
2009-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DOCET_L_04827
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None